EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot–Marie–Tooth disease 4H

Lara El-Bazzal, Adeline Ghata, Clothilde Estève, Jihane Gadacha, Patrice Quintana, Christel Castro, Nathalie Roeckel-Trévisiol, Frédérique Lembo, Nicolas Lenfant, André Mégarbané, Jean-Paul Borg, Nicolas Lévy und 5 weitere

Brain · 2023

DOI: 10.1093/brain/awac402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Lara El-Bazzal und 16 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Univ, INSERM, MMG, U 1251, Marseille, France. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, French Association against Myopathies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Charcot–Marie–Tooth (CMT) disease is one of the most common inherited neurological disorders, affecting either axons from the motor and/or sensory neurons or Schwann cells of the peripheral nervous system (PNS) and caused by more than 100 genes. We previously identified mutations in FGD4 as responsible for CMT4H, an autosomal recessive demyelinating form of CMT disease. FGD4 encodes FRABIN, a GDP/GTP nucleotide exchange factor, particularly for the small GTPase Cdc42. Remarkably, nerves from patients with CMT4H display excessive redundant myelin figures called outfoldings that arise from focal hypermyelination, suggesting that FRABIN could play a role in the control of PNS myelination. To gain insights into the role of FGD4/FRABIN in Schwann cell myelination, we generated a knockout mouse model (Fgd4SC–/–), with conditional ablation of Fgd4 in Schwann cells. We show that the specific deletion of FRABIN in Schwann cells leads to aberrant myelination in vitro, in dorsal root ganglia neuron/Schwann cell co-cultures, as well as in vivo, in distal sciatic nerves from Fgd4SC–/– mice. We observed that those myelination defects are related to an upregulation of some interactors of the NRG1 type III/ERBB2/3 signalling pathway, which is known to ensure a proper level of myelination in the PNS. Based on a yeast two-hybrid screen, we identified SNX3 as a new partner of FRABIN, which is involved in the regulation of endocytic trafficking. Interestingly, we showed that the loss of FRABIN impairs endocytic trafficking, which may contribute to the defective NRG1 type III/ERBB2/3 signalling and myelination. Using RNA-Seq, in vitro, we identified new potential effectors of the deregulated pathways, such as ERBIN, RAB11FIP2 and MAF, thereby providing cues to understand how FRABIN contributes to proper ERBB2 trafficking or even myelin membrane addition through cholesterol synthesis. Finally, we showed that the re-establishment of proper levels of the NRG1 type III/ERBB2/3 pathway using niacin treatment reduces myelin outfoldings in nerves of CMT4H mice. Overall, our work reveals a new role of FRABIN in the regulation of NRG1 type III/ERBB2/3 NRG1signalling and myelination and opens future therapeutic strategies based on the modulation of the NRG1 type III/ERBB2/3 pathway to reduce CMT4H pathology and more generally other demyelinating types of CMT disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseAnimalsMiceGuanine Nucleotide Exchange FactorsMice, KnockoutMutationNeuregulin-1Schwann CellsSciatic NerveSorting NexinsErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-3

Stichwörter der Autor:innen

Charcot–Marie–ToothNRG1/ERBB2/3endocytic traffickingmyelin outfoldingsniacin treatment

Substanzen

Guanine Nucleotide Exchange FactorsNeuregulin-1Sorting NexinsNrg1 protein, mouseSnx3 protein, mouseErbb2 protein, mouseErb-b2 Receptor Tyrosine KinasesErbB3 protein, mouseReceptor, ErbB-3

Autor:innen und Institutionen

  • Aix Marseille Univ, INSERM, MMG, U 1251, Marseille, France.
  • Aix Marseille Univ, INSERM, CNRS, CRCM, Institut Paoli-Calmettes, Marseille, France.
  • Department of Human Genetics, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.
  • Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, USA.

ORCID-Profile: Marc Bartoli, Yannick Poitelon, Valérie Delague, Nathalie Bernard-Marissal

Förderung

  • NINDS NIH HHS
  • French Association against Myopathies

Zitieren

APA

El-Bazzal, L., Ghata, A., Estève, C., Gadacha, J., Quintana, P., Castro, C., Roeckel-Trévisiol, N., Lembo, F., Lenfant, N., Mégarbané, A., Borg, J. P., Lévy, N., Bartoli, M., Poitelon, Y., Roubertoux, P. L., Delague, V., & Bernard-Marissal, N. (2023). Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot–Marie–Tooth disease 4H. Brain. https://doi.org/10.1093/brain/awac402

Vancouver

El-Bazzal L, Ghata A, Estève C, Gadacha J, Quintana P, Castro C, et al. Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot–Marie–Tooth disease 4H. Brain. 2023. doi:10.1093/brain/awac402

BibTeX
@article{ElBazzal2023,
  author = {El-Bazzal, Lara and Ghata, Adeline and Estève, Clothilde and Gadacha, Jihane and Quintana, Patrice and Castro, Christel and Roeckel-Trévisiol, Nathalie and Lembo, Frédérique and Lenfant, Nicolas and Mégarbané, André and Borg, Jean-Paul and Lévy, Nicolas and Bartoli, Marc and Poitelon, Yannick and Roubertoux, Pierre L and Delague, Valérie and Bernard-Marissal, Nathalie},
  title = {Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot–Marie–Tooth disease 4H},
  journal = {Brain},
  year = {2023},
  doi = {10.1093/brain/awac402}
}
Kostenlos starten →